Attached files
| file | filename |
|---|---|
| EX-99.1 - FMC PRESENTATION - FMC CORP | dex991.htm |
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
March 18, 2010
FMC CORPORATION
(Exact name of registrant as specified in its charter)
| Delaware | 1-2376 | 94-0479804 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
1735 Market Street, Philadelphia, PA 19103
(Address of principal executive offices) (Zip Code)
(215) 299-6000
Registrant’s telephone number, including area code
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act |
| ¨ | Soliciting material pursuant to Rule 14a-2 under the Exchange Act |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act |
| Item 7.01. | Regulation FD Disclosure. |
On March 18, 2010, Pierre Brondeau, President and CEO, and W. Kim Foster, Senior Vice President and CFO, of FMC Corporation, met with investors during the UBS Chemicals Conference held in Boston, MA. Slides used in their meetings at the conference are included hereto as an exhibit.
This report is not deemed “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section.
| Item 9.01. | Financial Statements and Exhibits. |
| (d) | Exhibits |
| 99.1 | FMC presentation by Pierre Brondeau and W. Kim Foster at the UBS Chemicals Conference held in Boston, MA on March 18, 2010. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| FMC CORPORATION | ||
| By: | /s/ W. KIM FOSTER | |
| W. Kim Foster Senior Vice President and Chief Financial Officer | ||
Date: March 18, 2010
EXHIBIT INDEX
| Exhibit Number |
Description | |
| 99.1 | FMC presentation by Pierre Brondeau and W. Kim Foster at the UBS Chemicals Conference held in Boston, MA on March 18, 2010. | |